Криоконсервация ткани пуповины человека: перспективы клинического применения

1. Арутюнян И.В., Макаров А.В., Ельчанинов А.В., Фатхудинов Т.Х. Мультипотентные мезенхимальные стромальные клетки пупочного канатика: биологические свойства и клиническое применение. Гены и клетки. 2015; 10(2): 30-8.

2. Низяева Н.В., Волкова Ю.С., Муллабаева С.М., Щеголев А.И. Методические основы изучения ткани плаценты и оптимизация режимов предподготовки материала. Акушерство и гинекология. 2014; 8: 10-8.

3. Щеголев А.И. Современная морфологическая классификация повреждений плаценты. Акушерство и гинекология. 2016; 4: 16-23.

4. Tuan-Mu H.Y., Yu C.H., Hu J.J. On the decellularization of fresh or frozen human umbilical arteries: implications for small-diameter tissue engineered vascular grafts. Ann. Biomed. Eng. 2014; 42(6): 1305-18. doi: 10.1007/s10439-014-1000-1.

5. Gui L., Muto A., Chan S.A., Breuer C.K., Niklason L.E. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng. Part A. 2009; 15(9): 2665-76. doi: 10.1089/ten.TEA.2008.0526.

6. Hoenicka M., Lehle K., Jacobs V.R., Schmid F.X., Birnbaum D.E. Properties of the human umbilical vein as a living scaffold for a tissue-engineered vessel graft. Tissue Eng. 2007; 13(1): 219-29.

7. Crouzier T., McClendon T., Tosun Z., McFetridge P.S. Inverted human umbilical arteries with tunable wall thicknesses for nerve regeneration. J. Biomed. Mater. Res. A. 2009; 89(3): 818-28. doi: 10.1002/jbm.a.32103.

8. Abousleiman R.I., Reyes Y., McFetridge P., Sikavitsas V. The human umbilical vein: a novel scaffold for musculoskeletal soft tissue regeneration. Artif. Organs. 2008; 32(9): 735-42. doi: 10.1111/j.1525-1594.2008.00598.x.

9. Cooke M., Tan E.K., Mandrycky C., He H., O’Connell J., Tseng S.C. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissue. J. Wound Care. 2014; 23(10): 465-74, 476. doi: 10.12968/jowc.2014.23.10.465.

10. Papanna R., Fletcher S., Moise K.J. Jr., Mann L.K., Tseng S.C. Cryopreserved human umbilical cord for in utero myeloschisis repair. Obstet. Gynecol. 2016; 128(2): 325-30. doi: 10.1097/AOG.0000000000001512.

11. Raphael A., Gonzales J. Use of cryopreserved umbilical cord with negative pressure wound therapy for complex diabetic ulcers with osteomyelitis. J. Wound Care. 2017; 26(Sup.10): S38-44. doi: 10.12968/jowc.2017.26.Sup10.S38.

12. Rozati H., Handley T., Jayasena C.N. Process and pitfalls of sperm cyopreservation. J. Clin. Med. 2017; 6(9). pii: E89. doi: 10.3390/jcm6090089.

13. Choudhery M.S., Badowski M., Muise A., Pierce J., Harris D.T. Cryopreservation of whole adipose tissue for future use in regenerative medicine. J. Surg. Res. 2014; 187(1): 24-35. doi: 10.1016/j.jss.2013.09.027.

14. Devitt S.M., Carter C.M., Dierov R., Weiss S., Gersch R.P., Percec I. Successful isolation of viable adipose-derived stem cells from human adipose tissue subject to long-term cryopreservation: positive implications for adult stem cell-based therapeutics in patients of advanced age. Stem Cells Int. 2015; 2015: 146421. doi: 10.1155/2015/146421.

15. Park B.W., Jang S.J., Byun J.H., Kang Y.H., Choi M.J., Park W.U. et al. Cryopreservation of human dental follicle tissue for use as a resource of autologous mesenchymal stem cells. J. Tissue Eng. Regen. Med. 2017; 11(2): 489-500. doi: 10.1002/term.1945.

16. Carnevale G., Pisciotta A., Riccio M., De Biasi S., Gibellini L., Ferrari A. et al. Optimized cryopreservation and banking of human bone-marrow fragments and stem cells. Biopreserv. Biobank. 2016; 14(2): 138-48. doi: 10.1089/bio.2015.0001.

17. Saleh R., Reza H.M. Short review on human umbilical cord lining epithelial cells and their potential clinical applications. Stem Cell Res. Ther. 2017; 8(1): 222. doi: 10.1186/s13287-017-0679-y.

18. Tanaka M., Tsuno N.H., Fujii T., Todo T., Saito N., Takahashi K. Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma. Cancer Sci. 2013; 104(2): 200-5. doi: 10.1111/cas.12055.

19. Chatzistamatiou T.K., Papassavas A.C., Michalopoulos E., Gamaloutsos C., Mallis P., Gontika I. et al. Optimizing isolation culture and freezing methods to preserve Wharton’s jelly’s mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion. 2014; 54(12): 3108-20. doi: 10.1111/trf.12743.

20. Da-Croce L., Gambarini-Paiva G.H., Angelo P.C., Bambirra E.A., Cabral A.C., Godard A.L. Comparison of vitrification and slow cooling for umbilical tissues. Cell Tissue Bank. 2013; 14(1): 65-76. doi: 10.1007/s10561-012-9301-9.

21. Choudhery M.S., Badowski M., Muise A., Harris D.T. Utility of cryopreserved umbilical cord tissue for regenerative medicine. Curr. Stem Cell Res. Ther. 2013; 8(5): 370-80.

22. Badowski M., Muise A., Harris D.T. Mixed effects of long-term frozen storage on cord tissue stem cells. Cytotherapy. 2014; 16(9): 1313-21. doi: 10.1016/j.jcyt.2014.05.020.

23. Roy S., Arora S., Kumari P., Ta M. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton’s jelly mesenchymal stem cells. Cryobiology. 2014; 68(3): 467-72. doi: 10.1016/j.cryobiol.2014.03.010.

24. Романов Ю.А., Балашова Е.Е., Волгина Н.Е., Кабаева Н.В., Дугина Т.Н., Сухих Г.Т. Выделение мультипотентных мезенхимальных стромальных клеток после криогенного хранения ткани пупочного канатика человека. Клеточные технологии в биологии и медицине. 2015; 4: 218-23.

25. Dulugiac M., Moldovan L., Zarnescu O. Comparative studies of mesenchymal stem cells derived from different cord tissue compartments - The influence of cryopreservation and growth media. Placenta. 2015; 36(10): 1192-203. doi: 10.1016/j.placenta.2015.08.011.

26. Shimazu T., Mori Y., Takahashi A., Tsunoda H., Tojo A., Nagamura-Inoue T. Serum- and xeno-free cryopreservation of human umbilical cord tissue as mesenchymal stromal cell source. Cytotherapy. 2015; 17(5): 593-600. doi: 10.1016/j.jcyt.2015.03.604.

27. ong C.Y., Subramanian A., Biswas A., Bongso A. Freezing of fresh Wharton’s jelly from human umbilical cords yields high post-thaw mesenchymal stem cell numbers for cell-based therapies. J. Cell. Biochem. 2016; 117(4): 815-27. doi: 10.1002/jcb.25375.

28. Shivakumar S.B., Bharti D., Subbarao R.B., Jang S.J., Park J.S., Ullah I. et al. DMSO- and serum-free cryopreservation of Wharton’s jelly tissue isolated from human umbilical cord. J. Cell. Biochem. 2016; 117(10): 2397-412. doi: 10.1002/jcb.25563.

29. Best B.P. Cryoprotectant toxicity: facts, issues, and questions. Rejuvenation Res. 2015; 18(5): 422-36. doi: 10.1089/rej.2014.1656.

30. Костяев А.А., Мартусевич А.К., Андреев А.А. Токсичность криопротекторов и криоконсервантов на их основе для компонентов крови и костного мозга (обзорная статья). Научное обозрение. Медицинские науки. 2016; 6: 54-74.

31. Rodríguez L., Velasco B., García J., Martín-Henao G.A. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion. 2005; 45(8): 1391-7.

32. Du T., Chao L., Zhao S., Chi L., Li D., Shen Y. et al. Successful cryopreservation of whole sheep ovary by using DMSO-free cryoprotectant. J. Assist. Reprod. Genet. 2015; 32(8): 1267-75. doi: 10.1007/s10815-015-0513-3.

33. Hartmann I., Hollweck T., Haffner S., Krebs M., Meiser B., Reichart B. et al. Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J. Immunol. Methods. 2010; 363(1): 80-9. doi: 10.1016/j.jim.2010.10.008.

34. Swamynathan P., Venugopal P., Kannan S., Thej C., Kolkundar U., Bhagwat S. et al. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study. Stem Cell Res. Ther. 2014; 5(4): 88. doi: 10.1186/scrt477.

Поступила 22.02.2018

Принята в печать 02.03.2018